These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25533501)

  • 21. A Novel BLyS Peptibody Down-Regulates B Cell and T Helper Cell Subsets In Vivo and Ameliorates Collagen-Induced Arthritis.
    Zhu W; Sun X; Zhu L; Gan Y; Baiwu R; Wei J; Li Z; Li R; Sun J
    Inflammation; 2016 Apr; 39(2):839-48. PubMed ID: 26861221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and effects of B-lymphocyte stimulator and its receptors in T cell-mediated autoimmune arthritis.
    Chang Y; Sun X; Jia X; Xu S; Wei F; Yang X; Wei W
    Int Immunopharmacol; 2015 Feb; 24(2):451-457. PubMed ID: 25598291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BAFF and APRIL as osteoclast-derived survival factors for myeloma cells: a rationale for TACI-Fc treatment in patients with multiple myeloma.
    Abe M; Kido S; Hiasa M; Nakano A; Oda A; Amou H; Matsumoto T
    Leukemia; 2006 Jul; 20(7):1313-5. PubMed ID: 16617317
    [No Abstract]   [Full Text] [Related]  

  • 24. Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator.
    Baker KP; Edwards BM; Main SH; Choi GH; Wager RE; Halpern WG; Lappin PB; Riccobene T; Abramian D; Sekut L; Sturm B; Poortman C; Minter RR; Dobson CL; Williams E; Carmen S; Smith R; Roschke V; Hilbert DM; Vaughan TJ; Albert VR
    Arthritis Rheum; 2003 Nov; 48(11):3253-65. PubMed ID: 14613291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting B-lymphocyte stimulator/B-cell activating factor and a proliferation-inducing ligand in hematologic malignancies.
    Shivakumar L; Ansell S
    Clin Lymphoma Myeloma; 2006 Sep; 7(2):106-8. PubMed ID: 17026820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In Silico Identification of Novel APRIL Peptide Antagonists and Binding Insights by Molecular Modeling and Immunosorbent Assays.
    Silva JH; Calmon-Hamaty F; Savino W; Hahne M; Caffarena ER
    Protein Pept Lett; 2015; 22(5):432-42. PubMed ID: 25731591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency.
    Lee JJ; Ozcan E; Rauter I; Geha RS
    Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):520-6. PubMed ID: 18978466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.
    Day ES; Cachero TG; Qian F; Sun Y; Wen D; Pelletier M; Hsu YM; Whitty A
    Biochemistry; 2005 Feb; 44(6):1919-31. PubMed ID: 15697217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity.
    Yu G; Boone T; Delaney J; Hawkins N; Kelley M; Ramakrishnan M; McCabe S; Qiu WR; Kornuc M; Xia XZ; Guo J; Stolina M; Boyle WJ; Sarosi I; Hsu H; Senaldi G; Theill LE
    Nat Immunol; 2000 Sep; 1(3):252-6. PubMed ID: 10973284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice.
    Wang H; Marsters SA; Baker T; Chan B; Lee WP; Fu L; Tumas D; Yan M; Dixit VM; Ashkenazi A; Grewal IS
    Nat Immunol; 2001 Jul; 2(7):632-7. PubMed ID: 11429548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic effects of TACI-Ig on rat with adjuvant arthritis.
    Wang D; Chang Y; Wu Y; Zhang L; Yan S; Xie G; Qin Q; Jin J; Wang W; Fang J; Wei W
    Clin Exp Immunol; 2011 Feb; 163(2):225-34. PubMed ID: 21155990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficient selection of IgG Fc domain-binding peptides fused to fluorescent protein using E. coli expression system and dot-blotting assay.
    Jeong YJ; Kang HJ; Bae KH; Kim MG; Chung SJ
    Peptides; 2010 Feb; 31(2):202-6. PubMed ID: 20025916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influenza virus host response of C57Bl/6 mice treated with TACI-Ig.
    Roque R; Ponce R; Burleson F; Cabrit M; Broly H; Rogge M
    Immunopharmacol Immunotoxicol; 2006; 28(1):13-32. PubMed ID: 16684665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BlyS is up-regulated by hypoxia and promotes migration of human breast cancer cells.
    Zhu J; Sun L; Lin S; Zhao R; Zhou L; Fang D; Chen L; Liu J; Shi W; Zhang L; Yuan S
    J Exp Clin Cancer Res; 2012 Mar; 31(1):31. PubMed ID: 22463935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity.
    Yan M; Marsters SA; Grewal IS; Wang H; Ashkenazi A; Dixit VM
    Nat Immunol; 2000 Jul; 1(1):37-41. PubMed ID: 10881172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A role for BLyS in the activation of innate immune cells.
    Chang SK; Arendt BK; Darce JR; Wu X; Jelinek DF
    Blood; 2006 Oct; 108(8):2687-94. PubMed ID: 16825497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation and accumulation of B cells in TACI-deficient mice.
    Yan M; Wang H; Chan B; Roose-Girma M; Erickson S; Baker T; Tumas D; Grewal IS; Dixit VM
    Nat Immunol; 2001 Jul; 2(7):638-43. PubMed ID: 11429549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression of TPO mimetic peptide chimeric proteins with human IgG1 Fc fragments and their biological characters].
    Li YX; Li C; Tao KH; Jia XH; Cheng DS; Huang PT
    Sheng Wu Gong Cheng Xue Bao; 2002 Jul; 18(4):424-30. PubMed ID: 12385237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The immunoregulator soluble TACI is released by ADAM10 and reflects B cell activation in autoimmunity.
    Hoffmann FS; Kuhn PH; Laurent SA; Hauck SM; Berer K; Wendlinger SA; Krumbholz M; Khademi M; Olsson T; Dreyling M; Pfister HW; Alexander T; Hiepe F; Kümpfel T; Crawford HC; Wekerle H; Hohlfeld R; Lichtenthaler SF; Meinl E
    J Immunol; 2015 Jan; 194(2):542-52. PubMed ID: 25505277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular Design of Peptide-Fc Fusion Drugs.
    Ning L; He B; Zhou P; Derda R; Huang J
    Curr Drug Metab; 2019; 20(3):203-208. PubMed ID: 30129406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.